PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 22, 2026Expert Review of Gastroenterology & Hepatology2 citations

Imaging in MASLD

View Full Paper
SVSudhakar K. Venkatesh

Key Points

  • The aim is to evaluate the role of imaging in the management of MASLD and its integration with clinical data.
  • Assessment of imaging techniques in MASLD
  • Integration of clinical data with imaging findings
  • Utilization of elastography for monitoring treatment
  • Improved risk stratification through noninvasive imaging
  • Enhanced individualized care recommendations
  • Effective monitoring of treatment progress with imaging and elastography

Abstract

Imaging is central to precision hepatology in MASLD, enabling comprehensive, noninvasive assessment and integration with clinical data for risk stratification. The integration of clinical data, imaging findings, and elastography will further enhance individualized care and treatment monitoring.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sudhakar K. Venkatesh (2026) studied this question.

synapsesocial.com/papers/699a9d3c482488d673cd3032https://doi.org/10.1080/17474124.2026.2636184
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Imaging of MASLD: clinical standards and novel methods2026 · 2 citations
  2. 2Non-Invasive Tests for the Detection of MASLD: Biomarkers and Imaging for Staging Steatosis, MASH, and Fibrosis2026 · 5 citations
  3. 3Integrated serum metabolomics and MRI biomarkers for MASLD: a practical framework for noninvasive staging and monitoring2026
  4. 4Imaging Biomarkers in Metabolic Dysfunction Associated Steatotic Liver Disease2025
  5. 5Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD2025